Challenges in tacrolimus dosing in mutant CYP3A5*3/3*renal transplant patients leading to over immunosuppression and persistent post-transplant covid viremia

被引：0
|
作者：
Chauhan, Sanjeev [1 ]
Sharma, Ashish [1 ]
Kenwar, Deepesh Benjamin [1 ]
Singh, Sarbpreet [1 ]
Patil, Shiva Kumar [1 ]
Patniak, Samita [2 ]
Karthik, Nasika Venkata Kanaka Naga [1 ]
Panjathia, Arun [1 ]
Bhushan, Bharat [1 ]
Reddy, Perugu Sai Praneeth [1 ]
Gysley, Belmin Winston [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Ranal Transplant Surg, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Clin Pharmacol, Chandigarh, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.075
引用
收藏
页码：482 / 482
页数：1
相关论文
共 50 条
  • [41] Trans-eQTLs of the CYP3A4 and CYP3A5 associated with tacrolimus trough blood concentration in Chinese renal transplant patients
    Lu, Huijie
    Jiang, Haixia
    Yang, Siyao
    Li, Chengcheng
    Li, Chuanjiang
    Shao, Ruifan
    Zhang, Pai
    Wang, Daoyi
    Liu, Zhiwei
    Qi, Huana
    Cai, Yinuan
    Xu, Wenbin
    Bao, Xiaojie
    Wang, Hailan
    Li, Liang
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
  • [42] Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patients
    Zhu, Wan
    Xue, Ling
    Peng, Hongwei
    Duan, Zhouping
    Zheng, Xuelian
    Cao, Duanwen
    Wen, Jinhua
    Wei, Xiaohua
    PHARMACOGENOMICS, 2018, 19 (13) : 1013 - 1025
  • [43] In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
    de Jonge, H.
    de Loor, H.
    Verbeke, K.
    Vanrenterghem, Y.
    Kuypers, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 366 - 375
  • [44] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [45] Influence of CYP3A5 polymorphisms on 5-year tacrolimus pharmacokinetics and renal function in renal transplant recipients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S710 - S710
  • [46] Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients
    Uno, Takaya
    Wada, Kyoichi
    Matsuda, Sachi
    Terada, Yuka
    Oita, Akira
    Kawase, Atsushi
    Takada, Mitsutaka
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (06) : 665 - 673
  • [47] The influence of genetic CYP3A5 polymorphism on tacrolimus serum concentration in liver transplant patients
    Albsoul-Younes, Abla
    Al-Jabra, Rabia
    Yousef, Almotessem
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1345 - 1345
  • [48] Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients
    Takaya Uno
    Kyoichi Wada
    Sachi Matsuda
    Yuka Terada
    Akira Oita
    Atsushi Kawase
    Mitsutaka Takada
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 665 - 673
  • [49] Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.
    Goel, Vivek
    Malik, Manish
    Bhalla, A. K.
    TRANSPLANTATION, 2024, 108 (9S)
  • [50] CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
    Spierings, N.
    Holt, D. W.
    MacPhee, Iain A. M.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 328 - 331
12345